Literature DB >> 2023222

Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.

S L Wallace1, J Z Singer, G J Duncan, F M Wigley, R W Kuncl.   

Abstract

In order to establish the degree of renal malfunction necessary for colchicine toxicity in patients receiving it daily for the prevention of recurrent acute gout, we obtained serum creatinine levels and measured or estimated creatinine clearances in a consecutive series of 17 patients with demonstrated colchicine myotoxicity. An estimate of creatinine clearance, based on ideal body weight and age, was nearly always 50 ml/min or less, and was the most practical predictor of the risk of toxicity. By comparison, patients with gout from the same clinical data base, but without myotoxicity, had normal renal function. The data yield clear guidelines for safe use of colchicine chronically.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023222

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  Colchicine myoneuropathy and renal dysfunction.

Authors:  S A Older; D S Finbloom; G H Pezeshkpour
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 2.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 4.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

5.  Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease.

Authors:  Suman Wason; David Mount; Robert Faulkner
Journal:  Clin Drug Investig       Date:  2014-12       Impact factor: 2.859

Review 6.  Prevention and management of gout.

Authors:  V L Star; M C Hochberg
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

7.  Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.

Authors:  Pornwalai Boonmuang; Surakit Nathisuwan; Nathorn Chaiyakunapruk; Wimon Suwankesawong; Pattreya Pokhagul; Nattawat Teerawattanapong; Pairin Supsongserm
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

Review 8.  Risks and benefits of drugs used in the management and prevention of gout.

Authors:  P G Conaghan; R O Day
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

9.  Colchicine-induced rhabdomyolysis.

Authors:  Arie Altman; Martine Szyper-Kravitz; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2007-07-10       Impact factor: 2.980

Review 10.  Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.

Authors:  George Nuki
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.